Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 222-228

  Craft, Suzanne ^a,b,c   Asthana, Sanjay ^a,c   Schellenberg, Gerard ^a,c   Baker, Laura ^a,c   Cherrier, Monique ^c   Boyt, Adam A ^d   Martins, Ralph N ^d   Raskind, Murray ^b,c   Peskind, Elaine ^b,c   Plymate, Stephen ^a,c  

^a Education   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; GLUCOSE; INSULIN;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEMORY; PATHOGENESIS; PROTEIN PROCESSING;

EID: 0034016848     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06371.x     Document Type: Conference Paper

References (13)

1. 1. CRAFT, S., E. PESKIND, M.W. SCHWARTZ et al. 1998. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50: 164-168.
2. 2. MARFAING, P., L. PENICAUD, Y. BROER et al. 1990. Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats. Neurosci. Lett. 115: 279-285.
3. 3. FROLICH, L., D. BLUM-DEGEN, H.G. BERNSTEIN et al. 1998. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Trans. 105: 423-438.
4. 4. CRAFT, S., J. NEWCOMER, S. KANNE et al. 1996. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17: 123-130.
5. 5. QIU, W.Q., D.M. WALSH, Z. YE et al. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 273: 32730-32738.
6. 6. BOYT, A.A., K. TADDEI, J. HALLMEYER et al. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Submitted manuscript.
7. 7. BERGMAN, R.N., Y.Z. IDER, C.R. BOWDEN & C. COBELLI. 1979. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236: E667-677.
8. 8. PERRET, E. 1974. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behavior. Neuropsychologia 12: 323-330.
9. 9. MARTINS, R.N., J. MUIR, W.S. BROOKS et al. 1993. Plasma amyloid precursor protein is decreased in Alzheimer's disease. Clin. Neurol. Neuropathol. 4: 757-759.
10. 10. OGBONNA, G., A. THERIAULT & K. ADELI. 1993. Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells. Int. J. Biochem. 25: 635-640.
11. 2-macroglobulin in adipocytes. J. Biol. Chem. 268: 974-981.
12. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37: 211-217.
13. 13. KOUNNAS, M.Z., R.D. MOIR, G.W. REBECK et al. 1995. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82: 331-340.